Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Diagnosed when there are specific deficits in an individualbs ability to perceive or process information efficiently and accurately. This disorder first manifests during the years of formal schooling and is characterized by persistent and impairing difficulties with learning foundational academic skills in reading, writing, and/or math. The individualbs performance of the affected academic skills is well below average for age, or acceptable performance levels are achieved only with extraordinary effort. Specific learning disorder may occur in individuals identified as intellectually gifted and manifest only when the learning demands or assessment procedures (e.g., timed tests) pose barriers that cannot be overcome by their innate intelligence and compensatory strategies. For all individuals, specific learning disorder can produce lifelong impairments in activities dependent on the skills, including occupational performance. (from dsm-V)
Biomarker and diagnostic research for specific learning disability has been reported in the published literature.
2 clinical trials registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
152 publications have been identified in PubMed for specific learning disability. Research spans Epidemiology / Natural History (30%), Review / Meta-Analysis (19%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 46 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:21 AM UTC
European rare disease database
Research summaries | 29 | 19% |
Laboratory research | 28 | 18% |
Clinical study results | 22 | 14% |
Testing and diagnosis research | 10 | 7% |
Other research | 9 | 6% |
Patient case studies | 8 | 5% |
Kapancık S (2026). [PMID: 41977269](https://pubmed.ncbi.nlm.nih.gov/41977269/). *Int J Mol Sci*. [Basic Science / Preclinical]
Sarid M (2026). [PMID: 41883103](https://pubmed.ncbi.nlm.nih.gov/41883103/). *J Learn Disabil*. [Epidemiology / Natural History]
O'Brien AM (2026). [PMID: 41994894](https://pubmed.ncbi.nlm.nih.gov/41994894/). *Int J Speech Lang Pathol*. [Review / Meta-Analysis]
Lee EJ (2026). [PMID: 42114847](https://pubmed.ncbi.nlm.nih.gov/42114847/). *J Korean Neurosurg Soc*. [Review / Meta-Analysis]
Serdengeçti N (2026). [PMID: 38757958](https://pubmed.ncbi.nlm.nih.gov/38757958/). *Applied neuropsychology. Child*. [Clinical Trial Publication]
Esen Öksüzoğlu M (2026). [PMID: 41260938](https://pubmed.ncbi.nlm.nih.gov/41260938/). *Journal of clinical and experimental neuropsychology*. [Clinical Trial Publication]
Harker B (2026). [PMID: 41984083](https://pubmed.ncbi.nlm.nih.gov/41984083/). *Lang Speech Hear Serv Sch*. [Clinical Trial Publication]
Bilgin N (2026). [PMID: 42159971](https://pubmed.ncbi.nlm.nih.gov/42159971/). *Acta Neurol Belg*. [Epidemiology / Natural History]
Rafikhah M (2026). [PMID: 42089258](https://pubmed.ncbi.nlm.nih.gov/42089258/). *Child Neuropsychol*. [Epidemiology / Natural History]
Lovett BJ (2026). [PMID: 41934613](https://pubmed.ncbi.nlm.nih.gov/41934613/). *J Clin Exp Neuropsychol*. [Epidemiology / Natural History]